Kirk Malloy has been promoted to vice president of customer solutions at Illumina, the company said last week. He joined the company in 2002 as senior director of customer solutions. Previously, he held positions at Biosite and Qiagen. Malloy received PhD and MS degrees in marine biology and biochemistry from the
Jonathan Rothberghas stepped down as chief executive officer of CuraGen, the company said last week. Rothberg, who announced his intention to resign as CEO in April, will remain on the CuraGen board of directors and be chairman of the board of 454 Life Sciences, a CuraGen subsidiary. Rothberg is replaced as CEO on an interim basis by Patrick Zenner, a CuraGen board member and former president and CEO of Hoffmann-La Roche.
Christopher McLeod has been named president and CEO of 454 Life Sciences. He used to be CuraGen's executive vice president.
John Gordon has become vice president of worldwide human resources of Millipore, the company said last week. Prior to joining Millipore, he was a consultant, and before that, corporate vice president of human resources for Sentara. Gordon holds an MBA from
John Lewis has become vice president of worldwide sales for Eklin Medical Systems, the Sunnyvale, Calif.-based digital radiography company said yesterday. He has held senior sales positions at Beckman Instruments, Molecular Dynamics, Alara and Celera Genomics. Lewis holds a BSc from the
David Schwartz will start his appointment as new director of the National Institute of Environmental Health Sciences and the National Toxicology Program on May 23, NIH said yesterday. He was named director of these institutes last fall. Schwartz comes to NIH from
Court Turner has been promoted to vice president of strategic alliances and senior legal counsel, Stewart Noble to vice president of discovery, and Andy Shiau to director of biology of Kalypsys, the San Diego-based company said on Monday. Turner, who joined Kalypsys in 2002 as director of legal affairs, holds a law degree from the University of San Diego and a degree in psychology from
The Ontario Genomics Institute has named five new directors to its board: John Molloy, president and chief executive officer of Parteq Innovations; Mark Poznansky, president and scientific director of the Robarts Research Institute; Cheryl Reicin, practice leader of the technology and life sciences group at Torys; Niclas Stiernholm, chief executive officer of Trillium Therapeutics; and Brian Underdown, managing director of technology investing at MDS Capital.
Molloy holds an MBA from Queen's University, Poznansky received a PhD in physiology from McGill University, Reicin has a JD from Harvard Law School and a BA from Columbia University, Stiernholm holds a PhD in immunology from the University of Toronto, and Underdown has a PhD in immunology from Washington University in St. Louis.
Alec Jeffreys was inducted to the National Inventors Hall of Fame last week for inventing genetic fingerprinting, the organization said last week. He is a researcher at the
Inventors may be nominated by anyone for induction into the Hall of Fame, but they must hold a
Mario Capecchi and Oliver Smithies have jointly won the 2005 March of Dimes Prize in Developmental Biology for developing the gene targeting technology, the March of Dimes Birth Defects Foundation said last week. Capecchi is a professor at the department of human genetics at the University of Utah School of Medicine. Smithies is a professor of pathology and laboratory medicine at the University of North Carolina Chapel Hill. The two researchers received the award, which comes with $250,000 in cash, at a ceremony last week.
Promoted? Changing jobs?GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.